Angiotensin II binding and extracellular matrix remodelling in a rat model of myocardial infarction

Clinical evidence points to a role for angiotensin II (Ang II) in the post-infarction remodelling of cardiac hypertrophy. The present study was designed to investigate the remodelling process in an animal model of myocardial infarction (MI) using the following criteria: 1) histological studies to ex...

Full description

Bibliographic Details
Main Authors: Marwan E El-Sabban, Khaled A Hassan, Adel E Birbari, Khalil M Bitar, Anwar B Bikhazi
Format: Article
Language:English
Published: SAGE Publications 2000-12-01
Series:Journal of the Renin-Angiotensin-Aldosterone System
Online Access:https://doi.org/10.3317/jraas.2000.069
_version_ 1797285418726588416
author Marwan E El-Sabban
Khaled A Hassan
Adel E Birbari
Khalil M Bitar
Anwar B Bikhazi
author_facet Marwan E El-Sabban
Khaled A Hassan
Adel E Birbari
Khalil M Bitar
Anwar B Bikhazi
author_sort Marwan E El-Sabban
collection DOAJ
description Clinical evidence points to a role for angiotensin II (Ang II) in the post-infarction remodelling of cardiac hypertrophy. The present study was designed to investigate the remodelling process in an animal model of myocardial infarction (MI) using the following criteria: 1) histological studies to examine the re-vascularisation process and collagen deposition in different regions of the myocardium; 2) histological evidence to investigate the cell type distribution using cell-specific markers; 3) histological and Western blot analysis to localise Ang II receptor subtypes (AT 1 -receptor and AT 2 -receptor) and to study their regulation; 4) kinetics of the binding of Ang II to its receptors in a heart perfusion model; and 5) to assess the effect of the Ang II antagonist (losartan) on these parameters. MI was induced by ligation of the left anterior descending coronary artery of Sprague-Dawley rats. Four different animal groups were established: 1) sham-operated, non-treated; 2) sham-operated, treated with losartan; 3) myocardial infarct, non-treated; and 4) myocardial infarct, treated with losartan. In infarcted rat hearts, fibroblasts and collagen types I and III increased in the remnant viable region of the left ventricle compared with sham-operated rats. One month of losartan treatment in myocardial infarcted rats revealed insignificant changes in fibroblasts and collagen types I and III compared with sham controls. Also, myocardial infarction increased AT 1 -receptor protein levels compared with sham-operated controls, as judged by Western blotting. In losartan-treated myocardial infarct animals, no changes were detected at the level of AT 1 -receptor expression compared with non-treated myocardial infarct rats. Binding studies of Ang II on endothelial cell lining and directly on myocytes in sham-operated and infarcted perfused rat hearts revealed that, in myocardial infarcted-animals, Ang II binding affinity increased both in the endothelium and in myofibres. This may be considered a major putative effect of the peptide in potentiating the pharmacodynamics of hypertrophy. In losartan-treated myocardial infarcted-animals, a marked increase in the binding affinities of Ang II for the AT 2 -receptor subtype was observed. Hence, potential cardioprotective effects of the AT 1 -receptor antagonist are proposed.
first_indexed 2024-03-07T18:02:56Z
format Article
id doaj.art-bf6f70941503438c97a69ab6795e5170
institution Directory Open Access Journal
issn 1470-3203
language English
last_indexed 2024-03-07T18:02:56Z
publishDate 2000-12-01
publisher SAGE Publications
record_format Article
series Journal of the Renin-Angiotensin-Aldosterone System
spelling doaj.art-bf6f70941503438c97a69ab6795e51702024-03-02T10:24:28ZengSAGE PublicationsJournal of the Renin-Angiotensin-Aldosterone System1470-32032000-12-01110.3317/jraas.2000.069Angiotensin II binding and extracellular matrix remodelling in a rat model of myocardial infarctionMarwan E El-SabbanKhaled A HassanAdel E BirbariKhalil M BitarAnwar B BikhaziClinical evidence points to a role for angiotensin II (Ang II) in the post-infarction remodelling of cardiac hypertrophy. The present study was designed to investigate the remodelling process in an animal model of myocardial infarction (MI) using the following criteria: 1) histological studies to examine the re-vascularisation process and collagen deposition in different regions of the myocardium; 2) histological evidence to investigate the cell type distribution using cell-specific markers; 3) histological and Western blot analysis to localise Ang II receptor subtypes (AT 1 -receptor and AT 2 -receptor) and to study their regulation; 4) kinetics of the binding of Ang II to its receptors in a heart perfusion model; and 5) to assess the effect of the Ang II antagonist (losartan) on these parameters. MI was induced by ligation of the left anterior descending coronary artery of Sprague-Dawley rats. Four different animal groups were established: 1) sham-operated, non-treated; 2) sham-operated, treated with losartan; 3) myocardial infarct, non-treated; and 4) myocardial infarct, treated with losartan. In infarcted rat hearts, fibroblasts and collagen types I and III increased in the remnant viable region of the left ventricle compared with sham-operated rats. One month of losartan treatment in myocardial infarcted rats revealed insignificant changes in fibroblasts and collagen types I and III compared with sham controls. Also, myocardial infarction increased AT 1 -receptor protein levels compared with sham-operated controls, as judged by Western blotting. In losartan-treated myocardial infarct animals, no changes were detected at the level of AT 1 -receptor expression compared with non-treated myocardial infarct rats. Binding studies of Ang II on endothelial cell lining and directly on myocytes in sham-operated and infarcted perfused rat hearts revealed that, in myocardial infarcted-animals, Ang II binding affinity increased both in the endothelium and in myofibres. This may be considered a major putative effect of the peptide in potentiating the pharmacodynamics of hypertrophy. In losartan-treated myocardial infarcted-animals, a marked increase in the binding affinities of Ang II for the AT 2 -receptor subtype was observed. Hence, potential cardioprotective effects of the AT 1 -receptor antagonist are proposed.https://doi.org/10.3317/jraas.2000.069
spellingShingle Marwan E El-Sabban
Khaled A Hassan
Adel E Birbari
Khalil M Bitar
Anwar B Bikhazi
Angiotensin II binding and extracellular matrix remodelling in a rat model of myocardial infarction
Journal of the Renin-Angiotensin-Aldosterone System
title Angiotensin II binding and extracellular matrix remodelling in a rat model of myocardial infarction
title_full Angiotensin II binding and extracellular matrix remodelling in a rat model of myocardial infarction
title_fullStr Angiotensin II binding and extracellular matrix remodelling in a rat model of myocardial infarction
title_full_unstemmed Angiotensin II binding and extracellular matrix remodelling in a rat model of myocardial infarction
title_short Angiotensin II binding and extracellular matrix remodelling in a rat model of myocardial infarction
title_sort angiotensin ii binding and extracellular matrix remodelling in a rat model of myocardial infarction
url https://doi.org/10.3317/jraas.2000.069
work_keys_str_mv AT marwaneelsabban angiotensiniibindingandextracellularmatrixremodellinginaratmodelofmyocardialinfarction
AT khaledahassan angiotensiniibindingandextracellularmatrixremodellinginaratmodelofmyocardialinfarction
AT adelebirbari angiotensiniibindingandextracellularmatrixremodellinginaratmodelofmyocardialinfarction
AT khalilmbitar angiotensiniibindingandextracellularmatrixremodellinginaratmodelofmyocardialinfarction
AT anwarbbikhazi angiotensiniibindingandextracellularmatrixremodellinginaratmodelofmyocardialinfarction